Physician profile
Patrick L Mills
NPI 1700844263
$3,176.53
in general payments reported to CMS, 2019-2025
42 companies · $797 in 2025
The $797 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $193 · 2021: $234 · 2022: $648 · 2023: $601 · 2024: $418 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,781 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.85 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $537.20 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $517.22 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Urovant Sciences INC | $191.48 | 2021-2022 | |
| Pfizer INC. | $182.63 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $139.99 | 2022-2024 | Pylarify |
| Urogen Pharma, INC. | $132.92 | 2022-2025 | Jelmyto |
| Coloplast Corp | $108.61 | 2019-2025 | Speedicath |
| Allergan, INC. | $105.75 | 2020 | |
| Procept Biorobotics Corporation | $93.52 | 2023-2025 | Aquabeam Robotic System |
| Abbvie INC. | $88.37 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.52 | 2020-2023 | |
| Immunitybio, INC. | $74.12 | 2025 | |
| Olympus America INC. | $59.17 | 2023-2025 | Itind System |
| Janssen Biotech, INC. | $57.86 | 2022-2025 | Erleada |
| Verity Pharmaceuticals INC. | $57.39 | 2024-2025 | Tlando, Trelstar |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.